Common Contracts
19 similar Executive Employment Agreement contracts by Inhibrx, Inc., Evofem Biosciences, Inc., XL Fleet Corp.
THIRD AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 7th, 2022 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Third Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2023 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Mark Lappe (“Executive”).
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 7th, 2022 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Second Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2023 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Kelly Deck (“Executive”).
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2021 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Second Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2022 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Klaus Wagner (“Executive”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2021 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2022 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Kelly Deck (“Executive”).
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2021 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Second Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2022 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Mark Lappe (“Executive”).
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2021 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Second Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2022 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Brendan Eckelman (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 1st, 2021 • XL Fleet Corp. • Motor vehicle parts & accessories • Delaware
This Executive Employment Agreement (this “Agreement”) is effective as of November 1, 2021 (the “Effective Date”) by and between XL Fleet Corp. (the “Company”), a Delaware corporation, and Eric Tech (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 12th, 2020 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (this “Agreement”) is effective as of August 7, 2020 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Kelly Deck (“Executive”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 12th, 2020 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of August 7, 2020 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Mark Lappe (“Executive”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 12th, 2020 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of August 7, 2020 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Brendan Eckelman (“Executive”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 12th, 2020 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Employment Agreement (this “Agreement”) is effective as of August 7, 2020 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Klaus Wagner (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • June 3rd, 2019 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2019 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Brendan Eckelman (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 7th, 2019 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2019 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Mark Lappe (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 7th, 2019 • Inhibrx, Inc. • Biological products, (no disgnostic substances) • California
This Executive Employment Agreement (this “Agreement”) is effective as of January 1, 2019 (the “Effective Date”) by and between Inhibrx, Inc., a Delaware corporation (the “Company”), and Klaus Wagner (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 3rd, 2018 • Evofem Biosciences, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (this “Agreement”) is made and entered into this 2nd day of July, 2018 (the “Effective Date”) by and between Evofem Biosciences, Inc., a Delaware corporation (“Company”), and Russ Barrans (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 3rd, 2018 • Evofem Biosciences, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (this “Agreement”) is made and entered into this 2nd day of July, 2018 (the “Effective Date”) by and between Evofem Biosciences, Inc., a Delaware corporation (“Company”), and Justin J. File (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 3rd, 2018 • Evofem Biosciences, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (this “Agreement”) is made and entered into this 2nd day of July, 2018 (the “Effective Date”) by and between Evofem Biosciences, Inc. a Delaware corporation (“Company”), and Saundra Pelletier (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 3rd, 2018 • Evofem Biosciences, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (this “Agreement”) is made and entered into this 2nd day of July, 2018 (the “Effective Date”) by and between Evofem Biosciences, Inc., a Delaware corporation (“Company”), and Alexander Fitzpatrick (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 3rd, 2018 • Evofem Biosciences, Inc. • Pharmaceutical preparations • California
This Executive Employment Agreement (this “Agreement”) is made and entered into this 2nd day of July, 2018 (the “Effective Date”) by and between Evofem Biosciences, Inc., a Delaware corporation (“Company”), and Kelly Culwell, M.D. (“Executive”).
